Medicine

Ipek Ulkersoy, Umit Gul, Mehmet Yıldız, A. Tunc, Sevval Ozyildirim, Nergis Akay, Oguzhan Tin, Nursena Kologlu Ates, Elif Kılıç Konte, A. Gunalp, E. Aslan, Ayse Kalyoncu Ucar, S. Şahin, N. Kepil, K. Barut, O. Beser, S. Kuruğoğlu, F. Cokugras, Ozgur Kasapcopur

2026.1.15Journal of Digestive Diseases

DOI: 10.1111/1751-2980.70028

tlooto Summary

Evaluated the prevalence of IBD and identified potential early markers for its recognition in children with JSpA, trying to improve its diagnostic, screening, and treatment strategies.

Abstract

Juvenile spondyloarthritis (JSpA) shares genetic, immunopathogenic, and environmental features with pediatric inflammatory bowel disease (IBD), placing patients at an elevated risk for IBD. We aimed to evaluate the prevalence of IBD and identify potential early markers for its recognition in children with JSpA, trying to improve its diagnostic, screening, and treatment strategies.

Citation format

ULKERSOY, Ipek, et al. The prevalence of inflammatory bowel disease in juvenile spondyloarthritis. Journal of Digestive Diseases, 2026, 26(11-12): 518–529.